Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Mar 2021 for Finch Therapeutics Group, Inc., €1.5M.
Filing timeline
BuySaleDomenic J. Ferrante
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Domenic J. Ferrante: trading record in brief
This profile gathers the share dealings of Domenic J. Ferrante in Finch Therapeutics Group, Inc. Altogether 4 filings, all relating to 23 March 2021.
On the market, this insider has only ever bought: 1 purchase, €1.5M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
The record was last updated on 25 March 2021 with an open-market purchase (€1.5M) in Finch Therapeutics Group, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Domenic J. Ferrante
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
102,941 shares@ US$17.00100.0% of flowCommon StockSEC:0001209191-21-023073:3
Canonical exit: 21 Jun 2021 (T+90)
300,948 sharesCommon StockSEC:0001209191-21-023073:1
90,378 sharesCommon StockSEC:0001209191-21-023073:2
141,928 sharesCommon StockSEC:0001209191-21-023073:0
4 of 4 declarations
